PERKI Pekanbaru

50 Abonné

acute coronary syndrome secondary prevention stemi statin antiplatelet reperfusion therapy complication rosuvastatin rivaroxaban oral anticoagulant anticoagulant mechanical complication cardiogenic shock metabolic angina trimetazidine echocardiography diagnostic angiotensin receptor blocker congestive heart failure patophysiology thrombosis ems clopidogrel ace inhibitors arrhythmia fibrinolytic primary pci beta blocker enoxaparine enoxaparine coronary heart disease cardiac biomarkers ticagrelor inflammation

Tout plus

Activité
À propos

PERKI Pekanbaru

Présentations

Role of Inflammation in Patophysiology of ACS

Role of More Potent Antiplatelet in ACS Management

Cardiac Biomarkers in ACS

Global Burden of Coronary Heart Disease

Enoxaparin Proven Across the ACS Spectrum

Secondary Prevention after ACS - Role of Beta Blockers

Haemodynamic Instability in STEMI

Primary PCI

Fibrinolytic Therapy

Electrical Instability in ACS

Role of ACE Inhibitors as Secondary Prevention in ACS

New Option of Antiplatelet and Controversies in ACS Treatment

Emergency Medical System Network for STEMI Management

Patophysiology of ACS: Role of Thrombosis

Role of Statin in Secondary Prevention of ACS

Recent Updated Pathogenesis and Management of Heart Failure:

Echocardiography for Acute Coronary Syndrome

Angina Management with Metabolic Agents

Secondary Prevention after ACS: Focused on Anticoagulant Therapy

Strategy to Go for Goal in Dyslipidemia with Acute Coronary Syndrome Patients